Literature DB >> 11895940

In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.

Federico Sisti1, Julieta Fernández, María Eugenia Rodríguez, Antonio Lagares, Nicole Guiso, Daniela Flavia Hozbor.   

Abstract

Bordetella bronchiseptica is closely related to Bordetella pertussis, which produces respiratory disease primarily in mammals other than humans. However, its importance as a human pathogen is being increasingly recognized. Although a large amount of research on Bordetella has been generated regarding protein virulence factors, the participation of the surface lipopolysaccharide (LPS) during B. bronchiseptica infection is less understood. To get a better insight into this matter, we constructed and characterized the behavior of an LPS mutant with the deepest possible rough phenotype. We generated the defective mutant B. bronchiseptica LP39 on the waaC gene, which codes for a heptosyl transferase involved in the biosynthesis of the core region of the LPS molecule. Although in B. bronchiseptica LP39 the production of the principal virulence determinants adenylate cyclase-hemolysin, filamentous hemagglutinin, and pertactin persisted, the quantity of the two latter factors was diminished, with the levels of pertactin being the most greatly affected. Furthermore, the LPS of B. bronchiseptica LP39 did not react with sera obtained from mice that had been infected with the parental strain, indicating that this defective LPS is immunologically different from the wild-type LPS. In vivo experiments demonstrated that the ability to colonize the respiratory tract is reduced in the mutant, being effectively cleared from lungs within 5 days, whereas the parental strain survived at least for 30 days. In vitro experiments have demonstrated that, although B. bronchiseptica LP39 was impaired for adhesion to human epithelial cells, it is still able to survive within the host cells as efficiently as the parental strain. These results seem to indicate that the deep rough form of B. bronchiseptica LPS cannot represent a dominant phenotype at the first stage of colonization. Since isolates with deep rough LPS phenotype have already been obtained from human B. bronchiseptica chronic infections, the possibility that this phenotype arises as a consequence of selection pressure within the host at a late stage of the infection process is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895940      PMCID: PMC127836          DOI: 10.1128/IAI.70.4.1791-1798.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene.

Authors:  R Deora; H J Bootsma; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

3.  A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro.

Authors:  P A Spears; L M Temple; P E Orndorff
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

4.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis.

Authors:  A Ray; K Redhead; S Selkirk; S Poole
Journal:  FEMS Microbiol Lett       Date:  1991-04-15       Impact factor: 2.742

7.  Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.

Authors:  T Abramson; H Kedem; D A Relman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Variation in Bordetella bronchiseptica lipopolysaccharide during human infection.

Authors:  P Gueirard; K Le Blay; A Le Coustumier; R Chaby; N Guiso
Journal:  FEMS Microbiol Lett       Date:  1998-05-15       Impact factor: 2.742

10.  Bordetella bronchiseptica-mediated cytotoxicity to macrophages is dependent on bvg-regulated factors, including pertactin.

Authors:  C B Forde; X Shi; J Li; M Roberts
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

View more
  7 in total

1.  Bordetella bronchiseptica Glycosyltransferase Core Mutants Trigger Changes in Lipid A Structure.

Authors:  Adriana C Casabuono; Federico Sisti; Julieta Fernández; Daniela Hozbor; Alicia S Couto
Journal:  J Am Soc Mass Spectrom       Date:  2019-06-12       Impact factor: 3.109

2.  Cyclic di-GMP Regulates the Type III Secretion System and Virulence in Bordetella bronchiseptica.

Authors:  María de la Paz Gutierrez; Ting Y Wong; Fredrick Heath Damron; Julieta Fernández; Federico Sisti
Journal:  Infect Immun       Date:  2022-05-25       Impact factor: 3.609

3.  Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens.

Authors:  Benito Lorenzo-Pajuelo; José Luis Villanueva; Juan Rodríguez-Cuesta; Nuria Vergara-Irigaray; Máximo Bernabeu-Wittel; Andrés Garcia-Curiel; Guillermo Martínez de Tejada
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

4.  Cyclic-di-GMP signalling regulates motility and biofilm formation in Bordetella bronchiseptica.

Authors:  Federico Sisti; Dae-Gon Ha; George A O'Toole; Daniela Hozbor; Julieta Fernández
Journal:  Microbiology       Date:  2013-03-08       Impact factor: 2.777

5.  Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity.

Authors:  Jeroen Geurtsen; Monika Dzieciatkowska; Liana Steeghs; Hendrik-Jan Hamstra; Johanna Boleij; Kelly Broen; Grietsje Akkerman; Hassan El Hassan; Jianjun Li; James C Richards; Jan Tommassen; Peter van der Ley
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

6.  Homologs of the LapD-LapG c-di-GMP Effector System Control Biofilm Formation by Bordetella bronchiseptica.

Authors:  Nicolás Ambrosis; Chelsea D Boyd; George A O Toole; Julieta Fernández; Federico Sisti
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

7.  Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector.

Authors:  Dawn L Taylor-Mulneix; Liron Bendor; Bodo Linz; Israel Rivera; Valerie E Ryman; Kalyan K Dewan; Shannon M Wagner; Emily F Wilson; Lindsay J Hilburger; Laura E Cuff; Christopher M West; Eric T Harvill
Journal:  PLoS Biol       Date:  2017-04-12       Impact factor: 8.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.